NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
| Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
| Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
| UBS Group AG | 1,785 | $5,000 | 0.00% |